These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20355207)

  • 1. Stability-indicating methods for the determination of a mixture of almitrine and raubasine by derivative spectrophotometry.
    El-Sayed MA
    Drug Test Anal; 2009 Jun; 1(6):279-85. PubMed ID: 20355207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability-indicating high performance liquid chromatographic determination of raubasine in its binary mixture with kinetic study of raubasine acid degradation.
    El-Sayed MA
    Talanta; 2011 Jan; 83(3):717-23. PubMed ID: 21147311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability-indicating spectrophotometric methods for determination of tazarotene in the presence of its alkaline degradation product by derivative spectrophotometric techniques.
    Badawy AM; El-Alim Ael-A; Saad AS
    Drug Test Anal; 2010 Mar; 2(3):130-6. PubMed ID: 20878894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S100-8. PubMed ID: 2093414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
    Sebban C; Tesolin B; Coulomb B; Berthaux P
    Exp Gerontol; 1989; 24(1):11-24. PubMed ID: 2707311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the EEG effects of the combination of almitrine and raubasine in animals and humans.
    Sebban C; Tesolin B; Schatz C; Malbezin M; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S50-8. PubMed ID: 2093418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
    Sebban C; Berthaux P
    Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo].
    Rapisarda V; Azzaro E; Fichera G
    Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
    Cahn R; Cahn J
    Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
    Carbonin PU; Greco A; Pisanti P; Gemma A; Cattelin F
    Clin Neuropharmacol; 1990; 13 Suppl 3():S92-9. PubMed ID: 2093422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.
    Li S; Long J; Ma Z; Xu Z; Li J; Zhang Z
    Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine.
    Sebban C
    Eur Neurol; 1995; 35 Suppl 1():37-42. PubMed ID: 8529728
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
    Chan P
    Eur Neurol; 1995; 35 Suppl 1():23-7. PubMed ID: 8529726
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability-indicating methods for determination of pyritinol dihydrochloride in the presence of its precursor and degradation product by derivative spectrophotometry.
    Shehata MA; el-Sayed MA; el-Bardicy MG; el-Tarras MF
    J AOAC Int; 2005; 88(1):80-6. PubMed ID: 15759729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
    Poitrenaud J; Laurent B; Sebban C
    Eur Neurol; 1995; 35 Suppl 1():43-6. PubMed ID: 8529729
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of a tissue oxygenator (almitrine + raubasine) on the metabolism of 2,3-diphosphoglycerate of rabbits submitted by hypoxia].
    Callis A; Dorance M; Magnan de Bornier B
    C R Seances Soc Biol Fil; 1980; 174(6):1006-9. PubMed ID: 6451260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial fibrillary acidic protein expression after transient brain ischemia: evidence for a pharmacological modulation by almitrine-raubasine.
    Pujol JF; Ginovart N; Debure L; Rousset C; Weissmann D
    Eur Neurol; 1995; 35 Suppl 1():12-6. PubMed ID: 8529723
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
    Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S109-16. PubMed ID: 2093415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological features of an almitrine-raubasine combination. Activity at cerebral levels.
    Benzi G
    Eur Neurol; 1998; 39 Suppl 1():31-8. PubMed ID: 9516073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach.
    Bentué-Ferrer D; Decombe R; Reymann JM; Schatz C; Allain H
    Clin Neuropharmacol; 1990; 13 Suppl 3():S9-25. PubMed ID: 2093421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.